Longs Drug Stores Corporation (NYSE: LDG) is doing something which may seem odd to many, which is essentially a "going with the bird in the hand" strategy. The company has just announced that its board of directors has determined not to have buyout discussions with Walgreens (NYSE: WAG). This was after consultation with its legal and financial advisors. Walgreens had sent Longs an expression of interest that was announced on September 12.
Longs has decided to proceed with itsmerger offer from CVS Caremark (NYSE: CVS). There are many reasonscited for this rejection including regulatory concerns, a lack of aroadmap, a lack of shareholder compensation over delays, and theexpression of interest being non-binding.
Longs shares are actually down almost 2% at $75.00 in pre-markettrading. Here is the issue at hand. The CVS bid is $71.50 andWalgreens has indicated that it is willing to pay $75.00. There aresome potential antitrust problems and it is believed by many that arival bid would take much longer into 2009 to close than the CVS offer.
Now it boils down to one thing: Will Walgreens come back with a higher bid that forces Longs’ board of directors to play along?
Jon C. Ogg
September 17, 2008
Cash Back Credit Cards Have Never Been This Good
Credit card companies are at war, handing out free rewards and benefits to win the best customers. A good cash back card can be worth thousands of dollars a year in free money, not to mention other perks like travel, insurance, and access to fancy lounges. See our top picks for the best credit cards today. You won’t want to miss some of these offers.
Flywheel Publishing has partnered with CardRatings for our coverage of credit card products. Flywheel Publishing and CardRatings may receive a commission from card issuers.
Thank you for reading! Have some feedback for us?
Contact the 24/7 Wall St. editorial team.